Tag:#Tilray

German Medical Cannabis Milestone As First Homegrown Flowers Distributed To Patients

HOMEGROWN medical cannabis is now available to German patients for the first time. Aphria RX– a wholly-owned subsidiary of Canadian pharmaceutical and cannabis company Tilray...

Six Companies Chosen to Supply Products – Free Of Charge – To France’s First Medical Cannabis Trial

SIX companies have seen their products selected for use in the French medical cannabis trial for 3,000 patients which is set to begin with...

Markets: UK CBD Firm’s Stock Price Up 1000% In 2020, Tilray & Aphria, EMMAC et al…

THIS time last year cannabis businesses were in the doldrums so the picture currently being viewed would have seemed a mirage back then. Stock prices...

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...
- Advertisement -spot_imgspot_img

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...